1,3-SUBSTITUTED-2-IMIDAZOLIDINONE DERIVATIVE, PROMOTER FOR GASTROINTESTINAL MOTION AND ITS PREPARATION

NEW MATERIAL:A compound shown by the formula I {A is group shown by the formula II [R1 and R2 are H, Cl, or RO- (R is lower alkyl)], or group shown by the formula III; B is group shown by the formula IV (R3 is H, or group shown by the formula V-VII; R4 is H, or OH); n is 2, or 3}, its acid addition...

Full description

Saved in:
Bibliographic Details
Main Authors TOMIYAMA ITARU, TOMIYAMA TAKESHI
Format Patent
LanguageEnglish
Published 17.03.1986
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:NEW MATERIAL:A compound shown by the formula I {A is group shown by the formula II [R1 and R2 are H, Cl, or RO- (R is lower alkyl)], or group shown by the formula III; B is group shown by the formula IV (R3 is H, or group shown by the formula V-VII; R4 is H, or OH); n is 2, or 3}, its acid addition salt. EXAMPLE:1-(m-Chlorophenyl)-3-[2-( N-benzylpiperidin-4-yl )amino]ethyl-2-imidazolidinone.hydrochloride. USE:A promoter for gastrointestinal motion, having low action like prolactin. PREPARATION:A compound shown by the formula IX is reacted with a compound shown by the formula X-(CH2)n-B(X ia halogen).
Bibliography:Application Number: JP19840175153